% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zimmer:147295,
author = {P. Zimmer$^*$ and M. E. Schmidt$^*$ and M. T. Prentzell$^*$
and B. Berdel$^*$ and J. Wiskemann and K. H. Kellner and J.
Debus and C. Ulrich and C. A. Opitz$^*$ and K.
Steindorf$^*$},
title = {{R}esistance {E}xercise {R}educes {K}ynurenine {P}athway
{M}etabolites in {B}reast {C}ancer {P}atients {U}ndergoing
{R}adiotherapy.},
journal = {Frontiers in oncology},
volume = {9},
issn = {2234-943X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2019-02416},
pages = {962},
year = {2019},
abstract = {Purpose: Evidence from preclinical studies and trials in
healthy volunteers suggests that exercise may modulate the
levels of tryptophan (TRP) metabolites along the kynurenine
(KYN) pathway. As KYN and downstream KYN metabolites are
known to promote cancer progression by inhibiting anti-tumor
immune responses and by promoting the motility of cancer
cells, we investigated if resistance exercise can also
control the levels of KYN pathway metabolites in breast
cancer patients undergoing radiotherapy (NCT01468766).
Patients and Methods: Chemotherapy-naïve breast cancer
patients (n = 96) were either randomized to an
exercise/intervention group (IG) or a control group (CG).
The IG participated in a 12-week supervised progressive
resistance exercise program twice a week, whereas the CG
received a supervised relaxation program. Serum levels of
TRP and KYN as well as urine levels of kynurenic acid (KYNA)
and neurotoxic quinolinic acid (QUINA) were assessed before
(t0), after radiotherapy, and mid-term of the exercise
intervention (t1) and after the exercise intervention (t2).
Additionally, 24 healthy women (HIG) participated in the
exercise program to investigate potential differences in its
effects on KYN metabolites in comparison to the breast
cancer patients. Results: At baseline (t0) the breast cancer
patients showed a significantly elevated serum KYN/TRP ratio
and urine QUINA/KYNA ratio, as well as increased urine QUINA
levels in comparison to the healthy women. In response to
exercise the healthy women and the breast cancer patients
differed significantly in the levels of urine QUINA and the
QUINA/KYNA ratio. Most importantly, serum KYN levels and the
KYN/TRP ratio were significantly reduced in exercising
patients (IG) compared to non-exercising patients (CG) both
at t1 and t2. Conclusion: Resistance exercise may represent
a potent non-pharmacological avenue to counteract an
activation of the KYN pathway in breast cancer patients
undergoing radiotherapy.},
cin = {C110 / B350 / L101},
ddc = {610},
cid = {I:(DE-He78)C110-20160331 / I:(DE-He78)B350-20160331 /
I:(DE-He78)L101-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31612110},
pmc = {pmc:PMC6773833},
doi = {10.3389/fonc.2019.00962},
url = {https://inrepo02.dkfz.de/record/147295},
}